Clinical trial
Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall…
NCT00227994 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00227994 |
|---|---|
| Title | Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke |
| Official title | Donepezil/ Galantamine in the Treatment of Post-stroke Cognitively Impaired Rehabilitating Elderly |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident |
| Intervention type | Drug |
| Interventions | Galantamine, Donepezil |
| Enrollment | 40 |
| Start date | Apr 1, 2003 |
| Primary completion | Jan 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Sep 28, 2005 |
| Last update posted | Dec 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: